DalsnaFinance

Labcorp $LH

Health Care · Health Care Services · NYSE/NASDAQ

S&P 500 Russell 1000 North Carolina
Create a scorecard
$322.33
+3.50 (+1.10%)
As of Oct 20, 2026, 10:34 AM EDT
Price history
Loading chart…

Key facts

52-week range (closes)
$246.64 – $339.34 Lowest close Nov 6, 2025, highest Aug 24, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Next earnings
Oct 28, 2026, before the open · EPS forecast $4.65 Nasdaq earnings calendar, as of Oct 20, 2026
Fiscal year ends
December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since
Nov 1, 2004 · All S&P 500 changes

Labcorp (LH) is trading up at $322.33 (+1.10%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Labcorp revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$14.0B$6.99B$0FY2016 revenue: $9.55BFY2016 net income: $711.8M · Net margin 7.5%'16FY2017 revenue: $10.3BFY2017 net income: $1.23B · Net margin 11.9%'17FY2018 revenue: $11.3BFY2018 net income: $883.7M · Net margin 7.8%'18FY2019 revenue: $11.6BFY2019 net income: $823.8M · Net margin 7.1%'19FY2020 revenue: $14.0BFY2020 net income: $1.56B · Net margin 11.1%'20FY2021 revenue: $13.1BFY2021 net income: $2.38B · Net margin 18.1%'21FY2022 revenue: $11.9BFY2022 net income: $1.28B · Net margin 10.8%'22FY2023 revenue: $12.2BFY2023 net income: $418.0M · Net margin 3.4%'23FY2024 revenue: $13.0BFY2024 net income: $746.0M · Net margin 5.7%'24FY2025 revenue: $14.0BFY2025 net income: $876.5M · Net margin 6.3%'250%5%10%15%20%FY2016 net margin: 7.5%FY2017 net margin: 11.9%FY2018 net margin: 7.8%FY2019 net margin: 7.1%FY2020 net margin: 11.1%FY2021 net margin: 18.1%FY2022 net margin: 10.8%FY2023 net margin: 3.4%FY2024 net margin: 5.7%FY2025 net margin: 6.3%
Labcorp annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$9.55B$10.3B$11.3B$11.6B$14.0B$13.1B$11.9B$12.2B$13.0B$14.0B
Growth (year over year)+10.1%+7.9%+9.9%+2.0%+21.0%−6.0%−9.7%+2.5%+7.0%+7.2%
Gross profit$2.85B$3.09B$3.18B$3.25B$4.95B$4.99B$3.71B$3.36B$3.62B$4.01B
Gross margin29.9%30.0%28.0%28.1%35.4%38.0%31.3%27.7%27.9%28.8%
Operating income$1.27B$1.31B$1.33B$1.33B$2.45B$3.05B$1.44B$725.6M$1.09B$1.38B
Operating margin13.3%12.7%11.7%11.5%17.5%23.2%12.1%6.0%8.4%9.9%
Net income$711.8M$1.23B$883.7M$823.8M$1.56B$2.38B$1.28B$418.0M$746.0M$876.5M
Net margin7.5%11.9%7.8%7.1%11.1%18.1%10.8%3.4%5.7%6.3%
EPS (diluted)$6.82$11.81$8.61$8.35$15.88$24.39$13.97$4.77$8.84$10.46
Balance sheet
Cash and equivalents$433.6M$316.6M$426.8M$337.5M$1.32B$1.47B$320.6M$536.8M$1.52B$532.3M
Total assets$14.2B$16.7B$16.2B$18.0B$20.1B$20.4B$20.2B$16.7B$18.4B$18.4B
Total liabilities$8.73B$9.85B$9.19B$10.5B$10.6B$10.1B$10.0B$8.83B$10.3B$9.76B
Long-term debt$5.30B$6.34B$5.99B$5.79B$5.42B$5.42B$5.04B$4.05B$5.33B$5.08B
Shareholders' equity$5.52B$6.80B$7.05B$7.64B$9.44B$10.3B$10.1B$7.88B$8.05B$8.62B
Cash flow
Operating cash flow$1.20B$1.50B$1.31B$1.44B$2.14B$3.11B$1.96B$1.33B$1.59B$1.64B
Capital expenditure$278.9M$312.9M$379.8M$400.2M$381.7M$421.5M$429.3M$453.6M$489.9M$434.5M
Free cash flow$918.2M$1.19B$925.6M$1.04B$1.75B$2.69B$1.53B$874.1M$1.10B$1.21B
Dividends paid——————$195.2M$254.0M$243.1M$240.7M
Share buybacks$43.9M$338.1M$700.0M$450.0M$100.0M$1.67B$1.10B$1.00B$250.1M$450.0M

From Labcorp's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Labcorp vs the Health Care sector and the S&P 500

Labcorp's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Labcorp compared with the median Health Care company and the median S&P 500 company
MeasureLabcorpHealth Care (59 other S&P 500 companies)S&P 500 (502 other companies)
Revenue growth, latest fiscal year+7.2%+7.1%+7.0%
Net margin, latest fiscal year6.3%13.1%13.0%
Dividend per share, latest fiscal year$2.88$2.43$2.40
Share price change, 1 year+9.6%+19.8%+5.6%

Labcorp: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Labcorp included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About Labcorp

Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.

Source: Wikipedia — Labcorp

Headquarters
Burlington, North Carolina From SEC filings, Oct 2026

Recent News (20)

More Health Care stocks

Browse all companies →